Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
News Jan 20, 2014
Bruker Corporation has announced the election of Dr. Gilles Martin to its Board of Directors.
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life-sciences company which provides a range of analytical testing services to clients across multiple industries.
Dr. Martin founded the original Eurofins Scientific Nantes food authenticity laboratory in 1988 and is a past President of the French Association of private analytical laboratories, and the North American Technical Committee for Juice and Juice Products. Dr. Martin holds a Ph.D. in Statistics and Applied Mathematics and a Master of Science from Syracuse University.
Frank Laukien, Bruker’s President and CEO, stated: “It is my great pleasure to welcome Gilles Martin to the Bruker Board of Directors as an independent director. I believe that Gilles will contribute strongly to the Bruker Board due to his tremendous entrepreneurial accomplishments at Eurofins, and with his in-depth knowledge of the environmental testing, food safety analysis and pharma CRO markets.”
Dr. Martin commented: “I am very excited to join the Board of Bruker, as the Company is expanding in the applied markets where I have extensive experience based upon my work at Eurofins. I hope that my general business and specific industry expertise, combined with the good work already being done by Bruker in the applied and CRO markets, can contribute to further profitable growth and the creation of shareholder value at Bruker.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
UK Not Ready for Brexit’s Impact on Food, Report WarnsNews
Severe problems with the UK food system are likely unless issues are addressed, according to latest expert reportREAD MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018